BLAINTRAMUSCULAR, SUBCUTANEOUSINJECTABLE
Approved
Sep 2022
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
14
Mechanism of Action
Acetylcholine Release Inhibitors
Pharmacologic Class:
Acetylcholine Release Inhibitor
Indications (1)
Clinical Trials (5)
Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia With Botulinum Toxin Type A (BoNT-A)
Started Sep 2024
50 enrolled
Traumatic Brain Injury
A Study to Assess the Effectiveness of BOTOX (Botulinum Toxin Type A) Injections for the Change of Masseter Muscle Prominence in Adult Participants
Started Oct 2023
249 enrolled
Masseter Muscle Prominence
CLINICAL EFFECT OF BOTULINUM TOXIN TYPE A IN TREATMENT OF SPASTICITY
Started Mar 2019
70 enrolled
SpasticityBrain InjuriesSpinal Cord Injuries+1 more
Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Adult Participants Undergoing Open-chest Cardiac Surgery (NOVA)
Started Mar 2019
323 enrolled
Post-Operative Atrial Fibrillation
Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients
Started Jun 2015
239 enrolled
Spasticity